- Home
- VCEL vs TBBK Comparison
VCEL vs TBBK Comparison
Compare VCEL & TBBK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VCEL
- TBBK
- Stock Information
- Founded
- VCEL 1989
- TBBK 1999
- Country
- VCEL United States
- TBBK United States
- Employees
- VCEL N/A
- TBBK N/A
- Industry
- VCEL Biotechnology: Biological Products (No Diagnostic Substances)
- TBBK Major Banks
- Sector
- VCEL Health Care
- TBBK Finance
- Exchange
- VCEL Nasdaq
- TBBK Nasdaq
- Market Cap
- VCEL 2.8B
- TBBK 2.6B
- IPO Year
- VCEL 1997
- TBBK 2004
- Fundamental
- Price
- VCEL $59.07
- TBBK $55.87
- Analyst Decision
- VCEL Strong Buy
- TBBK Buy
- Analyst Count
- VCEL 7
- TBBK 3
- Target Price
- VCEL $62.29
- TBBK $56.33
- AVG Volume (30 Days)
- VCEL 424.2K
- TBBK 423.3K
- Earning Date
- VCEL 02-27-2025
- TBBK 01-30-2025
- Dividend Yield
- VCEL N/A
- TBBK N/A
- EPS Growth
- VCEL N/A
- TBBK 16.50
- EPS
- VCEL 0.07
- TBBK 3.95
- Revenue
- VCEL $226,844,000.00
- TBBK $472,068,000.00
- Revenue This Year
- VCEL $23.82
- TBBK N/A
- Revenue Next Year
- VCEL $22.51
- TBBK $10.40
- P/E Ratio
- VCEL $821.76
- TBBK $14.15
- Revenue Growth
- VCEL 22.48
- TBBK 6.73
- 52 Week Low
- VCEL $38.69
- TBBK $29.92
- 52 Week High
- VCEL $61.49
- TBBK $61.17
- Technical
- Relative Strength Index (RSI)
- VCEL 57.96
- TBBK 57.29
- Support Level
- VCEL $53.00
- TBBK $54.19
- Resistance Level
- VCEL $60.93
- TBBK $56.02
- Average True Range (ATR)
- VCEL 2.60
- TBBK 1.67
- MACD
- VCEL -0.06
- TBBK 0.43
- Stochastic Oscillator
- VCEL 76.54
- TBBK 89.32
About VCEL Vericel Corporation
Vericel Corp is a fully integrated, commercial-stage biopharmaceutical company, specialized in various therapies for sports medicine and severe burn care markets. It markets two cell therapy products in the United States, MACI (autologous cultured chondrocytes on porcine collagen membrane) and Epicel (cultured epidermal autografts). The company operates in one reportable segment: the research, product development, manufacture, and distribution of patient-specific, expanded cellular therapies for use in the treatment of specific diseases.
About TBBK The Bancorp Inc
The Bancorp Inc is a financial holding company, through its subsidiary it is engaged in specialty lending namely securities-backed lines of credit, vehicle fleet and another equipment leasing, Small Business Administration lending, insurance policy cash value-backed lines of credit and commercial mortgage-backed loans, generated for sale into commercial mortgage-backed securities markets through securitizations. The company deposits and non-interest income are generated in the payments business which consists of issuing, acquiring, and automated clearing house accounts.